![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
SwedishAmerican Health System |
---|---|
Information provided by: | SwedishAmerican Health System |
ClinicalTrials.gov Identifier: | NCT00243581 |
The objective of this study is to evaluate the effect of the Ornish Program on cardiovascular disease as measured by the IMT of the common carotid artery, and to compare this effect to outcomes from patients participating in traditional cardiac rehabilitation.
Condition | Intervention | Phase |
---|---|---|
a Myocardial Infarction Coronary Artery Bypass Graft Surgery Percutaneous Transluminal Coronary Angioplasty Stent Placement |
Behavioral: Dean Ornish Heart Disease Reversing Program |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Single Blind, Placebo Control, Single Group Assignment |
Official Title: | The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Patients will be accepted into the study if they demonstrate one or more of the following within the previous 12 months: a myocardial infarction, coronary artery bypass graft surgery, or percutaneous transluminal coronary angioplasty, stent placement, or rotoblator procedures. Patients will also accepted if they have stable angina as determined by the Rose Questionnaire or pacemaker associated with one or more of the previously mentioned diagnoses. For the purposes of this study, myocardial infarction is defined as the presence of at least two of the following three criteria: continuous chest pain lasting at least 30 minutes; electrocardiogram changes expressing an evolving myocardial infarction (ST segment elevation or depression, evolving Q waves, or symmetric inversion of T waves); or elevated cardiac enzyme levels (at least twice the I levels).
Exclusion Criteria:
-
Study ID Numbers: | SACCM Ornish Clinical Trial |
Study First Received: | October 21, 2005 |
Last Updated: | October 28, 2005 |
ClinicalTrials.gov Identifier: | NCT00243581 History of Changes |
Health Authority: | United States: Institutional Review Board |
Necrosis Heart Diseases Myocardial Ischemia Vascular Diseases |
Ischemia Infarction Myocardial Infarction |
Necrosis Heart Diseases Pathologic Processes Myocardial Ischemia Vascular Diseases |
Cardiovascular Diseases Ischemia Infarction Myocardial Infarction |